Clinical Reference Labs Makes At-Home COVID-19 Saliva Test Available Through Walgreens Find Care
WASHINGTON (dpa-AFX) - Clinical Reference Laboratory, privately held clinical testing laboratories in the U.S, said Wednesday that it makes first at-home COVID-19 saliva test available through Walgreens Find Care.
The FDA-authorized, saliva-based COVID-19 RT-PCR test expands testing access with a comfortable, at-home alternative - eliminating in-person waits and reducing exposure risk, Clinical Reference Laboratory said in a statement.
Clinical Reference Laboratory received FDA Emergency Use Authorization for its saliva-based COVID-19 RT-PCR test in July 2020. In the FDA filing, the test demonstrated 100 percent sensitivity and specificity. The test incorporates technology from trusted partners DNA Genotek and Co-Diagnostics.
Clinical trial at UAB studying way to clear âbrain fogâ from COVID-19 (Source: Pexels) By WBRC Staff | February 23, 2021 at 5:23 PM CST - Updated February 23 at 5:26 PM
BIRMINGHAM, Ala. (WBRC) - âBrain fogâ is what doctors call a change in cognitive function many COVID-19 patients experience as a long-term effect from the virus. The fog is marked by memory problems and a struggle to think clearly. A new clinical trial at the University of Alabama at Birmingham is testing a rehabilitation method to remedy the problem.
A report on 120 patients in France, published in October 2020, found that more than a third had memory loss and 27 percent had cognitive difficulties months after recovering from COVID-19. In another study, a hospital network in Chicago reported that, among 509 patients, nearly a third experienced altered mental function; of these, 68 percent were unable to handle routine daily activities such as cooking or paying bills.
Theralase Technologies Inc.: Theralase Launches Fifth Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
Theralase or the
TSXV:TLT)(
OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (
PDC ) and their associated drug formulations used to safely and effectively destroy various cancers, bacteria and viruses announced today that University of Wisconsin Health-Madison (
UWH ) has received site Institutional Review Board (
IRB ) approval to commence a pivotal Phase II Non-Muscle Invasive Bladder Cancer (
NMIBC ) Clinical Study to enroll and treat patients with Bacillus Calmette Guerin(
Study II ).
2020 has been a memorable year for Ryvu. Menarini, the partner sponsoring SEL24/MEN1703 development, completed the Phase I part of the Phase I/II trial in acute myeloid leukaemia (AML) and presented the